The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La RocheSee more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity - Oasiz - Horizon Therapeutics Ireland DACSee more
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - AmgenSee more
Diabetes
A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus - Hoffmann-La RocheSee more
Renal disease
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
